Therapeutic formulations and methods
The invention provides compositions and methods for treating cyanide poisoning.
1. A pharmaceutical composition comprising, sulfanegen lysine, lysine hydrochloride, and water.
2. The composition of claim 1 wherein the molar ratio of sulfanegenic acid:lysine is about 1:2.
3. The composition of claim 1 wherein the molar ratio of sulfanegenic acid:lysine:lysine hydrochloride is about 1:2:0.4.
4. The composition of claim 1 , which is formulated for intramuscular administration.
5. The composition of claim 1 , which is formulated for intravenous administration.
6. The composition of claim 1 having a pH of greater than about 4.
7. The composition of claim 1 having a pH of less than about 5.
8. The composition of claim 1 , which is formulated for intraosseous administration.
9. A pharmaceutical composition prepared by combining sulfanegen lysine, lysine hydrochloride, and water.
10. A pharmaceutical composition prepared by combining sulfanegenic acid and a solution of lysine in water.
11. A pharmaceutical composition prepared by combining sulfanegenic acid and a solution prepared by combining water, lysine and lysine hydrochloride.
12. A pharmaceutical composition comprising sulfanegenic acid solid, lysine solid, and lysine hydrochloride solid.
13. A pharmaceutical composition prepared by combining sulfanegenic acid solid, lysine solid, and lysine hydrochloride solid.
14. A method comprising combining a) a solution prepared by combining water, lysine and lysine hydrochloride and b) sulfanegenic acid to provide a resulting solution.
15. The method of claim 14 further comprising administering the resulting solution to an animal.
16. The method of claim 15 wherein the resulting solution is administered to the animal at least 1 hour after combining.
17. The method of claim 15 wherein the resulting solution is administered to the animal at least 15 hours after combining.
18. A method comprising combining a) water and b) sulfanegenic acid solid, lysine solid, and lysine hydrochloride solid to provide a resulting solution.
19. A kit comprising a) a solution prepared by combining water, lysine and lysine hydrochloride; b) sulfanegenic acid solid; and instructions for combining the solution and the solid to provide a composition suitable for treating cyanide poisoning.
20. A kit comprising a) sulfanegenic acid solid, lysine solid, and lysine hydrochloride solid; and instructions for combining the sulfanegenic acid solid, lysine solid, and lysine hydrochloride solid with water to provide a composition suitable for treating cyanide poisoning.
21. A nanoparticle comprising sulfanegen lysine and lysine hydrochloride.
22. A nanoparticle suspension comprising a plurality of nanoparticles as described in claim 21 .
23. A pharmaceutical composition comprising a plurality of nanoparticles as described in claim 21 and a pharmaceutically acceptable carrier.